Expression levels of tumor necrosis factor‑α and the corresponding receptors are correlated with trauma severity

Liu,Chang; Tang,Jianwei

doi:10.3892/ol.2014.2575

Expression levels of tumor necrosis factor‑α and the corresponding receptors are correlated with trauma severity

Authors:
- Chang Liu
- Jianwei Tang
View Affiliations

Affiliations: Department of Emergency Surgery, Jinshan Hospital, Fudan University, Shanghai 200540, P.R. China
Published online on: September 29, 2014 https://doi.org/10.3892/ol.2014.2575
Pages: 2747-2751

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study investigated the plasma levels of tumor necrosis factor α (TNF‑α) and the expression levels of TNF receptors (TNFRs) in patients with multiple trauma, together with the association between the levels of this cytokine and these cytokine receptors with the severity of traumatic injury. Blood samples were obtained from 60 multiple trauma patients at hospital admission (within 2 h of injury), and 6‑8 h and 1‑5 days after admission. The plasma levels of TNF‑α and TNFR1/TNFR2 were detected using enzyme immunoassay. TNFR1 and TNFR2 expression levels on leukocytes, including neutrophils, lymphocytes and monocytes, were determined by flow cytometry. Clinical parameters were determined by injury severity score (ISS). At hospital admission, the plasma TNF‑α and soluble TNFR levels in the trauma patients were elevated compared with those of healthy controls. Increased expression levels of TNFR1 and TNFR2 were also detected on leukocytes, particularly on lymphocytes and monocytes. The expression levels of the cytokine and the corresponding receptors were correlated with the ISS. TNF‑α and TNFR expression levels remained significantly elevated for up to the third to fifth day following the traumatic injury. In the trauma patients, increased levels of TNF‑α and TNFRs were correlated with the severity of traumatic injury in the early post‑injury period, supporting the hypothesis that trauma‑provoked organ dysfunction may be caused by an overwhelming auto‑destructive inflammatory response.

View Figures

View References

1	Lenz A, Franklin GA and Cheadle WG: Systemic inflammation after trauma. Injury. 38:1336–1345. 2007.
2	Esposito E and Cuzzocrea S: TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem. 16:3152–3167. 2009.
3	Woodcock T and Morganti-Kossmann MC: The role of markers of inflammation in traumatic brain injury. Front Neurol. 4:182013.
4	Vandenabeele P, Declercq W, Beyaert R and Fiers W: Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5:392–399. 1995.
5	Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H and Lesslauer W: Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:351–359. 1990.
6	Smith CA, Davis T, Anderson D, et al: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science. 248:1019–1023. 1990.
7	Goodwin RG, Anderson D, Jerzy R, et al: Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol Cell Biol. 11:3020–3026. 1991.
8	Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr and Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA. 88:9292–9296. 1991.
9	Choi SJ, Lee KH, Park HS, Kim SK, Koh CM and Park JY: Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes. Yonsei Med J. 46:818–826. 2005.
10	Cinat M, Waxman K, Vaziri ND, Daughters K, Yousefi S, Scannell G and Tominaga GT: Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J Trauma. 39:112–120. 1995.
11	Ertel W, Keel M, Bonaccio M, Steckholzer U, Gallati H, Kenney JS and Trentz O: Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma. 39:879–887. 1995.
12	Stein DM, Lindell A, Murdock KR, et al: Relationship of serum and cerebrospinal fluid biomarkers with intracranial hypertension and cerebral hypoperfusion after severe traumatic brain injury. J Trauma. 70:1096–1103. 2011.
13	Dalgard CL, Cole JT, Kean WS, et al: The cytokine temporal profile in rat cortex after controlled cortical impact. Front Mol Neurosci. 5:62012.
14	Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker WC and Abraham E: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med. 21:839–845. 1993.
15	Rabinovici R, John R, Esser KM, Vernick J and Feuerstein G: Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma. 35:698–702. 1993.
16	Tan LR, Waxman K, Scannell G, Ioli G and Granger GA: Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma. 34:634–638. 1993.
17	Cinat ME, Waxman K, Granger GA, Pearce W, Annas C and Daughters K: Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg. 179:529–537. 1994.
18	Svoboda P, Kantorová I and Ochmann J: Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma. 36:336–340. 1994.
19	Majetschak M, Flach R, Heukamp T, et al: Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J Trauma. 43:880–887. 1997.
20	Spielmann S, Kerner T, Ahlers O, Keh D, Gerlach M and Gerlach H: Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course. Acta Anaesthesiol Scand. 45:364–370. 2001.
21	Zerey M, Burns JM, Kercher KW, Kuwada TS and Heniford BT: Minimally invasive management of colon cancer. Surg Innov. 13:5–15. 2006.
22	Feldman AM: TNF alpha - still a therapeutic target. Clin Transl Sci. 1:1452008.
23	Kawasaki Y, Zhang L, Cheng JK and Ji RR: Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 28:5189–5194. 2008.
24	Oshima T, Lee S, Sato A, Oda S, Hirasawa H and Yamashita T: TNF-alpha contributes to axonal sprouting and functional recovery following traumatic brain injury. Brain Res. 1290:102–110. 2009.
25	Spinas GA, Keller U and Brockhaus M: Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest. 90:533–536. 1992.
26	Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL and Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA. 89:4845–4849. 1992.
27	Gerlach H, Gerlach M and Clauss M: Relevance of tumour necrosis factor-alpha and interleukin-1-alpha in the pathogenesis of hypoxia-related organ failure. Eur J Anaesthesiol. 10:273–285. 1993.
28	Rogy MA, Coyle SM, Oldenburg HS, et al: Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg. 178:132–138. 1994.
29	Pellegrini JD, Puyana JC, Lapchak PH, Kodys K and Miller-Graziano CL: A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality. Shock. 6:389–396. 1996.
30	Froon AH, Bemelmans MH, Greve JW, van der Linden CJ and Buurman WA: Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values. Crit Care Med. 22:803–809. 1994.
31	Balk RA: Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin. 16:337–352. 2000.
32	Esposito E and Cuzzocrea S: Anti-TNF therapy in the injured spinal cord. Trends Pharmacol Sci. 32:107–115. 2011.
33	Chio CC, Chang CH, Wang CC, et al: Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α. BMC Neurosci. 14:332013.
34	Shuh M, Bohorquez H, Loss GE Jr and Cohen AJ: Tumor necrosis factor-α: life and death of hepatocytes during liver ischemia/reperfusion injury. Ochsner J. 13:119–130. 2013.
35	Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H and DePuy V: Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 26:1051–1070. 2012.